Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Stories of Discovery
    • Chen Lecture Videos
    • Public Health & Economic Impact Study
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Active Patent Commercialization Licenses

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Persistent HIV-1 Infection of Natural Killer Cells In Patients Receiving Highly Active Antiretroviral Therapy

  • Read more about Persistent HIV-1 Infection of Natural Killer Cells In Patients Receiving Highly Active Antiretroviral Therapy
US Application 60/380,555
Filed on 2002-05-13

CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF.

  • Read more about CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF.
US Application 60/398,092
Filed on 2002-07-24

Identification of a Novel BHD Gene

  • Read more about Identification of a Novel BHD Gene
US Application 60/385,181
Filed on 2002-05-31

POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND...

  • Read more about POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND...
US Application 60/378,495
Filed on 2002-05-07

MRP9 AND ITS USE IN DETECTING AND TREATING CANCER

  • Read more about MRP9 AND ITS USE IN DETECTING AND TREATING CANCER
US Application 60/375,121
Filed on 2002-04-22

A Multi-Mode Therapeutic Regimen Spares HAART Treatment in HIV-1-Infected Individuals

  • Read more about A Multi-Mode Therapeutic Regimen Spares HAART Treatment in HIV-1-Infected Individuals
US Application 60/377,493
Filed on 2002-05-01

SH2 DOMAIN BINDING INHIBITORS

  • Read more about SH2 DOMAIN BINDING INHIBITORS
US Application 60/392,028
Filed on 2002-06-28

METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL ANION DONORS

  • Read more about METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL ANION DONORS
US Application 60/388,819
Filed on 2002-06-14

DNA Binding Polyamide Drug Conjugates

  • Read more about DNA Binding Polyamide Drug Conjugates
US Application 60/370,168
Filed on 2002-04-05

Conjugates of Ligand, Linker and Cytotoxic Agents and Related Composition And Methods of Use

  • Read more about Conjugates of Ligand, Linker and Cytotoxic Agents and Related Composition And Methods of Use
US Application 60/370,189
Filed on 2002-04-05

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 230
  • Page 231
  • Page 232
  • Page 233
  • Page 234
  • Page 235
  • Page 236
  • Page 237
  • Page 238
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health